Nuwellis Correlations
NUWE Stock | USD 0.24 0.02 7.69% |
The current 90-days correlation between Nuwellis and ReShape Lifesciences is 0.04 (i.e., Significant diversification). The correlation of Nuwellis is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Nuwellis Correlation With Market
Average diversification
The correlation between Nuwellis and DJI is 0.14 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Nuwellis and DJI in the same portfolio, assuming nothing else is changed.
Moving together with Nuwellis Stock
0.71 | FEMY | Femasys | PairCorr |
0.67 | MOH | Molina Healthcare | PairCorr |
0.66 | GCTK | GlucoTrack Upward Rally | PairCorr |
0.88 | KMTS | Kestra Medical Techn | PairCorr |
0.94 | LNSR | LENSAR Inc | PairCorr |
0.65 | TMCI | Treace Medical Concepts | PairCorr |
0.72 | VALN | Valneva SE ADR | PairCorr |
Moving against Nuwellis Stock
0.78 | MASS | 908 Devices | PairCorr |
0.73 | DH | Definitive Healthcare | PairCorr |
0.65 | NVNO | enVVeno Medical Corp | PairCorr |
0.64 | CAH | Cardinal Health | PairCorr |
0.63 | HAE | Haemonetics | PairCorr |
0.63 | INFU | InfuSystems Holdings Downward Rally | PairCorr |
0.61 | NVST | Envista Holdings Corp | PairCorr |
0.47 | JYNT | Joint Corp | PairCorr |
0.41 | XTNT | Xtant Medical Holdings | PairCorr |
0.86 | FBRX | Forte Biosciences | PairCorr |
0.71 | HSCSW | Heart Test Laboratories | PairCorr |
0.65 | DNA | Ginkgo Bioworks Holdings | PairCorr |
0.61 | ADUS | Addus HomeCare | PairCorr |
0.55 | POCI | Precision Optics, | PairCorr |
0.54 | HCM | HUTCHMED DRC | PairCorr |
0.53 | A | Agilent Technologies | PairCorr |
0.52 | UTMD | Utah Medical Products | PairCorr |
0.49 | CUPR | Cuprina Holdings | PairCorr |
0.36 | NYXH | Nyxoah | PairCorr |
0.35 | FLGC | Flora Growth Corp | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Nuwellis Stock performing well and Nuwellis Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Nuwellis' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
RSLS | 17.49 | 2.41 | 0.14 | (1.53) | 14.88 | 35.81 | 411.90 | |||
TNON | 4.26 | (1.86) | 0.00 | (1.27) | 0.00 | 4.46 | 35.61 | |||
RMED | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
INVO | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
THMO | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
SINT | 4.46 | 0.26 | 0.06 | 0.23 | 4.79 | 16.55 | 35.57 | |||
NAOV | 11.93 | 0.23 | 0.01 | (0.50) | 13.32 | 35.66 | 207.46 | |||
TIVC | 7.21 | 1.09 | 0.15 | 0.46 | 6.66 | 28.97 | 132.46 | |||
TLIS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
BJDX | 7.53 | 0.07 | 0.00 | (0.16) | 11.72 | 10.69 | 173.13 |
Nuwellis Corporate Management
Neil Esq | General VP | Profile | |
Robert Scott | Chief Officer | Profile | |
Laurent Duhoux | VP Devel | Profile | |
Rob Scott | Director Officer | Profile | |
William MD | VP Marketing | Profile |